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Report Details
Support and Training for the Evaluation of Programs (STEPs) at the 
University of Nebraska at Omaha is a leader in conducting evaluations of and 
needs assessments for social service programs and policies.  The Nebraska 
Department of Health and Human Services contracted with STEPs in the 
summer of 2019 to complete a needs assessment that includes a literature 
and web review to gauge the state of knowledge related to individuals’ drug 
use behaviors, to inform focus group questions, and to identify methods of 
future data collection.
Report Background
This foundational report informs the quantitative surveys and 
qualitative interviews STEPs will conduct with treatment providers in 
Nebraska. This report can be used by the Drug Overdose Prevention 
Program to develop state- and community-level crisis response plans to 
reduce drug misuse, substance use disorders, and drug overdoses.
3Key Findings
Executive Summary
Purpose
This report informs a needs assessment to 
gauge drug-use behaviors, treatment needs, 
and prevention efforts through the lens of 
treatment providers across Nebraska.
Methodology
After determining the scope of the literature 
review in collaboration with DHHS, 
researchers gathered relevant information 
from a variety of sources.  The primary areas 
of interest include:
• National and Nebraska statistics.
• Prevention.
• Initiation to drug use.
• Treatment.
Data Sources Used
This literature review includes a combination 
of scholarly articles, federal and state agency  
documents, and key stakeholder 
publications. Local news sources were also 
reviewed to capture current information 
relevant to Nebraska.
 Relieving pain was the most commonly 
reported reason for opioid misuse, but 
only 2% of people reported they misused 
opioids because they were addicted or 
needed to have the drug.6 
 Most people who initiated prescription 
opioid misuse in 2017 were over 26 years 
old.6 In contrast, most people who initiated 
use of marijuana, meth, and alcohol were 
between 18-25 years old.6
 Most prevention programs are aimed at 
youth because adolescent substance use is a 
predictor of developing a substance use 
disorder in adulthood.24 
 State-mandated use of the PDMP for 
prescribers has been effective in reducing 
the number of overdose deaths in other 
states.30
 At the national level, approximately 15 million people were in need of substance abuse 
treatment but did not receive any in 2017.6 For those who recognized they needed 
treatment, the number one reported barrier to treatment was not being ready to stop using.6
 Methamphetamines are the primary drug of concern for both Nebraska and the Midwest 
region.3 Heroin has also been found to be a significant concern for the Midwest region, but 
less so for Nebraska.3
4National and Nebraska Statistics
Introduction
Overdose deaths directly related to heroin and opioid pain relievers have been 
increasing both nationally and internationally.1 Within the United States, drug overdose deaths 
have increased from 9.3 to 16.3 per 100,000 people.2 Although Nebraska drug overdose deaths 
have not been impacted with the same magnitude, rates in opioid-related deaths from 2005 to 
2015 have increased from 2.4 per 100,000 to 3.0 per 100,000.2 National data from 2016 
indicates that 30% of drug overdoses were due to opioids.2
Table 1.1 was extracted from the 2018 Midwest High Intensity Drug Trafficking Area 
(HIDTA) Threat Assessment and shows the number of deaths attributed to overdose in the six 
states of the Midwest region.3 Four of the six states experienced an increase in the percent of 
overdose deaths from 2015 to 2016, while both Nebraska and Kansas showed a decrease.3
State 2015 2016 Difference
Iowa 309 314 + 2%
Kansas 329 313 − 5%
Missouri 1,066 1,371 + 30%
Nebraska 126 120 − 5%
North Dakota 61 77 + 26%
South Dakota 65 69 + 6%
All Midwest HIDTA states 1,956 2,264 + 16%
Table 1.1 Drug Overdose Deaths in the Midwest HIDTA Region, 2015 and 20163
An increased national focus on opioid abuse is primarily due to increased overdose 
deaths and hospitalizations associated with opioid use.  According to the Addiction Center, the 
number of deaths attributed to opioid abuse have increased to over 40,000 a year, or 115 
deaths a day.4 Accidental opioid-related overdose is now the leading cause of accidental death 
in the United States.4 It is imperative, therefore, to understand the factors leading to opioid 
abuse in the effort to reduce the number of overdose deaths nationwide. 
This report provides an overview of Nebraska-specific substance use data, protective 
and risk factors for substance use, and evidence-based practices for prevention and treatment.  
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National Statistics
Estimates from the 2017 National Survey on Drug Use and Health indicated 30 
million people 12 years of age or older were current illicit substance users.  This 
demonstrates a 20% increase from the estimated 25 million current illicit drug users in 2013.5,6
The 18- to 25-year-old age group had the highest percentage of illicit drug users in both years 
with 22% in 2013, and 24% in 2017.5,6
Table 1.2 shows the number of people who reported using illicit substances in the past 
month for 2013 and 2017.5,6
Current Use (within the past 30 days)
Substance 20135 20176
Marijuana 19.8 million 26 million
Pain relieversi 4.5 million 3.2 million
Cocaine 1.5 million 2.2 million
Stimulantsii 1.4 million 1.8 million
Tranquilizersiii 1.7 million 1.7 million
Methamphetamineiv 595,000 774,000
Heroin 289,000 494,000
Total 24.5 million 30.5 million
i. Includes hydrocodone, oxycodone, tramadol, codeine, morphine, fentanyl, buprenorphine, oxymorphone 
products, Demerol®, hydromorphone, methadone, or any other prescription pain reliever.
ii. Includes amphetamine products, methylphenidate products, anorectic (weight-loss) stimulants, Provigil®, 
or any other prescription stimulant.
iii. Includes benzodiazepine tranquilizers (including alprazolam products, lorazepam products, clonazepam 
products, or diazepam products), muscle relaxants, or any other prescription tranquilizer.
iv. Methamphetamine use was also included in stimulant use category for 2013 data.  Methamphetamine, 
produced or distributed illicitly, had its own category in 2017.
Table 1.2  National Current Illicit Drug Use in 2013 Compared to 2017
Marijuana was the most used illicit drug, followed by prescription pain relievers for 
both time frames.6 Although being the second most common illicit drug used in 
2017, “pain relievers” was the only drug to show a decrease from 2013.  The other six 
drug categories showed either an increase or stayed the same.
National and Nebraska Statistics
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Substance Number of Users
Opioids 11.4 million
Prescription pain relievers 11.1 million
Heroin 886,000
National Statistics
In 2017, 11.4 million people had misused opioids within the past year.6 Of those, 
the vast majority (11.1 million) misused prescription pain relievers compared to 
886,000 people who misused heroin.6 Most heroin users (64%) had also misused a 
prescription pain reliever in the past year, but only 5% of prescription pain reliever misusers 
also used heroin.  An estimated 6 out of 10 individuals who misused opioids noted the last 
time they misused opioids was to relieve physical pain (p. 1).6 Approximately half of people 
who misused opioids obtained the opioid from a friend or relative (p. 1).4
Table 1.3 provides national estimates on the overall misuse or illicit use of substances 
within the past year from the 2017 National Survey on Drug Use and Health.6
Table 1.3  National Illicit Drug Use in the Past Year for 2017
More opioid users reported using prescription pain relievers.
Nebraska Statistics
The 2018 Midwest High Intensity Drug Trafficking Area Threat Assessment (HIDTA) 
identifies illicit drug trends and concerns in Nebraska and the Midwest region’s six-
state area. Methamphetamines are ranked as the number one drug threat for both Nebraska 
and the Midwest region. The report notes that methamphetamine continues to increase in 
availability and decrease in price throughout Nebraska.3
The next drug of concern for Nebraska is controlled prescription drugs (CPDs); within 
the Midwest, CPDs are ranked third and heroin is ranked second. However, in Nebraska, 
heroin is less of a concern and is ranked fifth.3 Fentanyl, however, is described as a relatively 
new threat.3 Although the HIDTA report states that fentanyl has not been reported in more 
rural areas yet, STEPs’ recent survey and focus group analysis identified that fentanyl had 
penetrated in the more rural areas of the state.7 CPDs are believed to be readily and easily 
available within the Midwest region and Nebraska.
National and Nebraska Statistics
7Findings
Nebraska Statistics
Drug Threats
Understanding the drug threats at both the state and Midwest regional levels 
provides an opportunity for Nebraska to develop strategies to address current and 
emerging needs.  Table 1.4 shows the greatest drug threats in Nebraska and across the 
Midwest with methamphetamine ranked as the number one concern in both areas.3
Ranking Midwest Drug Threats Nebraska Drug Threats
1 Methamphetamine Methamphetamine
2 Heroin Prescription drugs
3 Prescription drugs Marijuana
4 Marijuana Cocaine
5 Cocaine Heroin
6 Synthetics/club drugs Synthetics/club drugs
Table 1.4  Greatest Drug Threats for Nebraska and across the Midwest
Methamphetamine is ranked as the number one concern for both 
Nebraska and the Midwest.
The 2018 Midwest HIDTA report provides an understanding of the emerging trends. 
The report surmises that the majority of the increase in drug overdose deaths in the region can 
be attributed to opioid abuse, particularly the abuse of heroin and synthetic opioids.3
The report further states that synthetic opioids are increasingly mixed with other drugs 
unbeknownst to the users.  This is perceived to be a factor in the current and future drug 
overdose death rates in the Midwest region.  There is particular concern for those who 
transition from prescription opioids to heroin and synthetic opioids, including non-
pharmaceutical fentanyl.
Nebraska Treatment Admission Demographics for 20178
There were 13,467 admissions to substance use treatment programs in Nebraska in 2017.  
The majority of people admitted were between 25 and 44 years old, non-Hispanic White, and 
male.
Age: 25-44 years old 
(59%, n=7,878)
Race: Non-Hispanic White 
(73%, n=9,225)
Gender: Male
(68%, n=9,128)
National and Nebraska Statistics
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Primary Substance Used 
at Admission
Number of 
Admissions
Alcohol only 5,660
Alcohol + secondary drug 1,924
Methamphetamine 3,141
Marijuana 1,309
Non-heroin opiates 371
Cocaine 160
Heroin 93
Total admissions 13,467
Table 1.5  2017 Substance Use Treatment Admissions for Nebraska8
Methamphetamine was the second most common substance at admission.
Nebraska Statistics
Nebraska Treatment Admissions
Substance use treatment programs in Nebraska processed 
13,467 admissions in 2017.8 This was the lowest number of 
admissions in Nebraska in the past 10 years, and substantially 
lower than the number of admissions in 2016 (n=18,098).8
Of the people admitted in Nebraska, nearly 4,000 reported 
being polysubstance users.  49% of those admitted reported 
polysubstance use with an illicit substance as their primary drug 
and alcohol as their secondary drug.8 However, no data was 
provided on the specific primary drugs used in these cases of 
polysubstance use.  About 51% of people admitted had alcohol as 
their primary drug with another substance as their secondary 
drug.8
It is important to note that a percentage of those who 
reported their primary drug as methamphetamine, marijuana, 
non-heroin opiates, cocaine, and heroin users may also be 
included in the 1,808 who use alcohol as their secondary drug. 
Table 1.5 shows the number of individuals admitted to 
substance use treatment based on their primary substance used.8
Polysubstance Use8
Polysubstance use 
admissions made up 
nearly half of all 
admissions in 2017.  In 
2017, there were:
• 3,732 polysubstance 
admissions.
• 1,924 of polysubstance 
admissions used 
alcohol as their 
primary drug and 
another drug as their 
secondary drug.
• 1,808 of polysubstance 
admissions used 
another drug as their 
primary drug and 
alcohol as their 
secondary drug.
National and Nebraska Statistics
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Risk and Protective Factors
With opioids being used more frequently for non-medical purposes, it becomes of 
interest to identify the risk and protective factors involved in ones likelihood to engage in 
substance use. 
Risk Factors
Risk factors for substance use are similar to risk factors for other concerning problems.  
Research demonstrates that the earlier a person begins using drugs, the more likely they are to 
develop both substance use and mental health disorders.9 Below is a listing of three primary 
types of risk factors identified in the literature:  Individual, Family, and Environmental.
National and Nebraska Statistics
Individual Risk Factors
 Previous substance use10
 Behavior disinhibition as an adolescent11
 Co-occurring mental illness11
 Experiencing online or in-person bullying10
 Psychological distress12
 Uninsured12
 Mental illness5
 Fewer years of education13
 Poor grades in school10
Family Risk Factors
 Cohabitation with parents who sold drugs or have been incarcerated13
 Cohabitation with partner who sold drugs or has been incarcerated13
 Parent or peer substance use as an adolescent11
 Parents who would not feel strongly about child drug use14
 Lack of a stable home or family5
 Residential mobility in adolescence15
 Genetic predisposition to substance use disorders 16
 Interpersonal violence, abuse, or neglect17
Environmental Risk Factors
 Adverse Childhood Experiences14
 Potentially traumatic experiences17
 Low food security (for women with or at risk for HIV)18
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Risk and Protective Factors
Methamphetamine-Specific Risk Factors
Risk factors for substance use are interrelated with risk factors for other physical, 
mental, and social problems.  Risk factors specific to methamphetamine users found within the 
literature are similar to risk factors for other substance use disorders.  However, the high threat 
of methamphetamine use in both Nebraska and the Midwest region prompt our mention of 
methamphetamine-specific factors.
Female methamphetamine users were more likely to be abused as a child, lived with 
parents/partner who sold drugs or had been incarcerated, had a mental health diagnosis, had 
children living with them, had fewer years of education, and began methamphetamine use 
earlier.13 Populations determined to be critically affected or disproportionally impacted by 
methamphetamine use include “incarcerated populations, LGBT individuals, women of 
childbearing years, American Indians/Alaska Natives, Latinos/Latinas, and Asian/Pacific 
Islander populations” (p. 11).20
Protective Factors
Protective factors are those characteristics at the individual, family, or environmental 
level that can potentially reduce the likelihood of developing a problem such as substance 
abuse.  The following protective factors are associated with positive outcomes in terms of 
substance use.
National and Nebraska Statistics
Individual Protective Factors
 Positive temperament9
 Social coping skills9
 Positive social orientation9
 Belief in one’s ability to control what happens and to adapt to change9
 Participating in extracurricular activities or groups10
 Participating in activities that prohibit drug or alcohol use10
 High self-esteem10
 Believing strongly in the risk and harm of drug use14
 Living in a rural area19
 Higher level of education19
Family Protective Factors
 Unity9
 Warmth9
 Parental attachment9
 Parental supervision9
 Contact and communication between parents and children9
11
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Risk and Protective Factors
Generational Differences
In addition to risk and protective factors, generational differences were also 
identified with respect to substance use.  Through analyzing data from the 2007-
2016 National Survey on Drug Use and Health, Baby Boomers were found to be at 
lower risk for all substance use (p. 3).21 In contrast, Millennials were significantly more likely 
to use cocaine, heroin, and OxyContin® than Generation X or Baby Boomers (p. 12).21
Generation X was found to be more at risk for polysubstance use and crack use (p. 9).21
Currently, Millennials are more at risk for substance use than any other generation.21
As demonstrated in the following graphs, at peak 
age, Baby Boomers’ use of stimulants such as 
methamphetamines was nearly three times that of 
Generation X or Millennials.21 A higher percentage of 
Millennials, however, use painkillers at all ages compared 
to Generation X or Baby Boomers.21
*Data from the 1987-2013 National Survey on Drug Use and Health were used in the preceding graphs.21
Substance Use by Generational Cohort
National and Nebraska Statistics
Environmental Protective Factors
 Positive emotional support outside the family (friends, neighbors)9
 Support and resources available to the family (family counseling, 
trauma programs, crisis lines)9
 Community and school norms, beliefs, and standards against substance 
use9
 Schools characterized by academic achievement and students who are 
committed to school9
 Attending a school with policies against substance use10
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Evidence-Based Prevention Programs
Categories of Prevention
Prevention programs are designed to decrease or eliminate risk factors and enhance 
protective factors.24 Evidence-based prevention programs are those strategies proven to 
be effective through high-caliber research.  
Substance abuse prevention programs are divided into three categories, which are 
defined in Table 2.1: Universal Prevention, Selective Prevention, and Indicative Prevention.14
Universal
Address risk and protective factors common among all people in a 
given setting (e.g. youth under 18 years old)
Selective
For groups who have specific factors that put them at increased risk 
of drug use (e.g. justice-involved youth)
Indicative Designed for those already using drugs
Prevention efforts are also divided into Levels of Prevention, as shown in Table 2.2.  
Unlike the Prevention Strategy Categories, Levels of Prevention are divided based on the stage 
of addiction or dependence.  For example, both Universal and Selective Prevention Strategies 
are considered to be implemented at the Primary level of prevention because they inhibit 
substance use initiation.  Both Indicative Strategies and Tertiary Levels of Prevention, however, 
are targets at those who are already involved in illicit substance use. 
Primary Preventing new cases of addiction from being initiated
Secondary
Interventions to prevent early substance use from moving to 
substance use disorder
Tertiary
Ensuring access to treatment and rehabilitation services (to 
prevent overdoses, medical complications, transition to injection 
drug use, injection-related diseases)
Table 2.1 Prevention Strategy Categories14
Table 2.2 Levels of Prevention26
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Evidence-Based Prevention Programs 
Primary Prevention
Universal prevention strategies target all people in a given context and are based on 
three main concepts:14,25
1. Parents and their children must understand that substance use in adolescence will 
affect their brain development.
2. Adolescents who view substance use as risky are significantly less likely to use drugs.
3. Substance use significantly decreases the longer substance use initiation is delayed. 
The Primary Level of Prevention has a narrower target population than Universal 
Prevention strategies because it aims to prevent new cases of substance use.  Most primary 
prevention strategies are aimed at youth because substance use disorders are 
development diseases that typically begin in adolescence.24 A risk factor for adult 
substance use disorders is illicit drug use during adolescence.  Prevention 
programs aim to instill an understanding of the risk of misusing substances 
during adolescence.  Between 2011 and 2012, only 0.3% of people who used an 
illicit drug for the first time were above the age of 26 (p. 12).24
Additionally, schools provide a useful setting for the implementation of prevention 
programs.  In contrast, implementing prevention programs for adults is more limited.  For 
adults who are not involved in the justice system, child welfare system, or treatment programs, 
media campaigns were the only primary prevention program aimed at illicit substance use. 
Methods of Prevention
Media campaigns are a method of prevention that can be used within any level or 
strategy of prevention.  In addition to being categorized by strategy (Universal, Selective, 
Indicative) and level (Primary, Secondary, Tertiary), SAMHSA presents six methods of 
prevention programs shown in Table 2.2.9
1. Information dissemination
Classroom speakers or media campaigns to 
increase knowledge and change beliefs
2. Prevention education
Teach social skills, such as resisting peer pressure 
or developing other healthy choice making skills
3. Positive alternatives
Structured, enjoyable activities to enjoy free time 
in healthy ways
Table 2.2 Methods of Prevention9
14
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Prevention
4. Environmental strategies
Change policies/conditions in work and 
socialization, such as enforcing liquor stores 
checking IDs
5. Community-based processes
Networking, planning, and coalition building 
to increase effective prevention and treatment 
strategies
6. Identification of problems and 
referral to services
Determine who is at risk and what 
interventions/protections need to be put in 
place
Table 2.2 Methods of Prevention (continued)9
For the purpose of this report, prevention programs supported by the literature will be 
divided into Universal, Selective, and Indicative, and then further divided by the implementation 
setting.
Universal: Address risk and protective factors common among all people in a 
given setting (e.g. youth under 18 years old).
School-Based27 • Caring School Community Program (now Center for the Collaborative 
Classroom)
• Classroom-Centered (CC) and Family-School Partnership (FSP) 
Intervention
• Promoting Alternative Thinking Strategies (PATHS)
• Guiding Good Choices
• Botvin Life Skills Training (LST) Program
• Lions-Quest Skills for Adolescence (SFA)
• Project ALERT
• The Strengthening Families Program: For Parents and Youth 10–14
• Lions-Quest Skills for Adolescence
• Project ALERT Plus
Community-Based • AWARxE Prescription Drug Safety Program
15
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Evidence-Based Prevention Programs
Universal: Address risk and protective factors common among all people in a 
given setting (e.g. youth under 18 years old).
Community-Based • Good Drugs Gone Bad 
• Generation RX 
• Above the Influence 
• Use Only As Directed 
• SAMHSA’s Strategic Prevention Framework (SPF)9
Policy • State-mandated prevention education in schools28
• Mandatory Prescriber Education Legislation
• Mandated use of the Prescription Drug Monitoring Program
Media or Social 
Media
• United States Drug Enforcement Agency Initiatives (may or may not 
be evidence-based):
• Red Ribbon Campaign
• National RX Drug Take Back Day
Selective:  For groups who have specific factors that put them at 
increased risk of drug use (e.g. justice-involved youth)
School-Based27 • Focus on Families (FOF) now known as Families Facing the Future
• The Strengthening Families Program (SFP)
• Coping Power
• Adolescents Training and Learning to Avoid Steroids (ATLAS)
Community-Based • Skills & Knowledge on Overdose Prevention (SKOOP)
• Drug Overdose Prevention & Education Project (DOPE)
• Behavioral Health Equity
• Communities that Care
• Creating Lasting Family Connections29
• Screening, Brief Intervention and Referral to Treatment (SBIRT)
• Project Lazarus
• Community Anti-Drug Coalitions of America 
16
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Selective:  For groups who have specific factors that put them at 
increased risk of drug use (e.g. justice-involved youth)
Policy • Integrating Substance Use Treatment into Mainstream Health Care14
• Opioid manufacturers develop formula difficult to inject or ingest 
intranasally30
Media or Social 
Media
• Partnership For Drugs-Free Kids (Drugfree.Org)
• Parent Addiction Network (PAN) 
https://safercommunity.net/parent-addiction-network-home/
• Medicine Abuse Project (medicineabuseproject.org) 
Indicative: Designed for those already using drugs
School-Based27 • Fast Track Prevention Trial for Conduct Problems
• Adolescent Transitions Program (ATP)
• Project Towards No Drug Abuse (Project TND)
• Reconnecting Youth Program (RY)
Community-Based • Healthy Lifestyle Coaching33 
Policy Opioid addiction most commonly develops in both medical and 
nonmedical users when taken orally (p. 566).30 A potential deterrent to 
further lessening the risk of opioid use is create oral forms of opioids 
that are difficult to misuse via intranasal or injection.  This does not 
prevent opioid misuse as a primary prevention measure; however, it 
does help prevention the potential of misusing it through injections.  
Recommended policy interventions include (pg. 32):30
• Dram Shop (Commercial Host ) Liability Laws, which hold 
businesses liable for selling alcohol to visibly intoxicated customers 
and for damages causes by significantly intoxicated customers.
• Electronic Screening and Brief Interventions.
• Mandated utilization of the PDMP and other health care system 
technologies
17
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Evidence-Based Prevention Programs
Indicative: Designed for those already using drugs
Media or Social 
Media
• Poster campaign to prevent the initiation of injection drug use
A media campaign to prevent street youth from initiating drug 
injection was carried out in 2005 in Montreal, Canada.29 The goal of 
the poster campaign was to prevent vulnerable street youth who 
seek social valorization from moving to injection drug use.29
Posters were hung in public places and community organizations 
frequently visited by street youth.  Surveys and interviews were 
conducted with youth who inject drugs.  
Surveyed youth who inject drugs found the campaign to be effective 
in preventing their peers from beginning drug injection and causing 
them to reflect on their own drug injection use.  
The “Scars” and “Wrists” posters were shown to be most impactful 
to interviewed youth.29 While this campaign was aimed at street 
youth, the potential effectiveness of the message on adults is 
unknown.  The posters used in the Canadian campaign are shown 
in the table below.29
18
Prevention
Harm Reduction Strategies (Indicative)
Harm reduction strategies fall under the Indicative strategy and Tertiary level of 
prevention.  Harm reduction strategies “provide public health-oriented, cost-
effective, and often cost-saving services to prevent and reduce substance use-related risks 
among those actively using substances, and substantial evidence supports their effectiveness” 
(p. 18).34 Examples of harm reduction strategies include: 
• needle or syringe exchange programs.
• safe injection sites.
• increased access and training to naloxone.
Research shows that needle and syringe exchange programs are effective in reducing 
HIV transmission without increasing injection drug use.14 They also provide the opportunity to 
engage with people who inject drugs as a point of referral for treatment or support services.14
Evidence supports clients in these syringe exchange programs being given naloxone and being 
trained on how to use it on their peers.26
Evidence-Based Prevention Programs
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Substance Use Initiation
Data from a cohort of individuals who were admitted into substance use treatment 
programs in 2017 were asked how old they were when they began their illicit drug use.  The 
majority of respondents indicated their drug use initiation began between the ages of 21 and 
24.  Of these, 54% indicated the primary substance leading up to the treatment admission was 
opioids (p. 55).8
Initiation to illicit drug use increased significantly between 2013 and 2017 for 
marijuana, pain relievers, tranquilizers, psychotherapeutic stimulants (including 
prescription forms of methamphetamine), and illicitly produced 
methamphetamine.5,6
Initiation of Drug Use
Substance 20135 20176
Marijuana 2.4 million 3 million
Nonmedical use of pain relieversi 1.5 million 2 million
Nonmedical use of tranquilizersii 1.2 million 1.4 million
Methamphetaminesiii
a. Nonmedical use or misuse of 
psychotherapeutic stimulants5,6
b. Methamphetamine, produced 
and distributed illicitly6
603,000
144,000
1.1 million
195,000
i. Includes products with hydrocodone, oxycodone, tramadol, codeine, morphine, fentanyl, buprenorphine, oxymorphone,  
Demerol®, hydromorphone, methadone, or any other prescription pain reliever.
ii. Includes benzodiazepine tranquilizers (including alprazolam products, lorazepam products, clonazepam products, or 
diazepam products), muscle relaxants, or any other prescription tranquilizer.
iii. In 2015, a new set of questions were created and administered separately from the questions about the misuse of 
prescription stimulants.1
Table 3.1 Illicit Drug by Number of Recent initiates
In contrast to initiation patterns of cigarettes, alcohol, meth, and marijuana, 
most people who initiated prescription opioid misuse in 2017 were 26 
years or older. The 18 to 25 age group was the largest age group of individuals who 
initiated methamphetamine use in 2017.6
Table 3.2 displays substance use initiation by age in 2017.
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Initiation of Drug Use
Substance Age 12-17 Age 18-25 Age 26 or older
Prescription pain reliever misuse 316,000 465,000 1.2 million
Psychotherapeutic stimulant misuse 217,000 581,000 394,000
Methamphetamine use 27,000 95,000 73,000
Substance Use Initiation
Table 3.2 Initiation by Age in 20176
Below are some additional facts regarding substance use initiation.
Urban and Rural Differences
According to the 2011–2012 National Survey on Drug Use and Health, urban individuals 
were significantly more likely to report cocaine, hallucinogen, and marijuana use (p. 26).12
Rural respondents were significantly more likely to report non-medical opioid use and 
meet the criteria for opioid-use disorder (p. 26).12 Rural respondents also had a lower 
probability of cocaine use compared to their urban counterparts (p. 27).12
Drug Injection Trends
According to a study in Baltimore, Maryland, people born after 1980 and who were 
currently injecting drugs were more likely to initiate drug use with prescription drugs 
compared to the initiation with heroin and cocaine of early generations.35 People born 
after 1980 and who were currently injecting drugs also had higher rates of polysubstance use 
prior to beginning injection drug use.35 People who inject drugs between 40 and 44 years of 
age had the highest rates of mortality, women in particular.35
Reasons for Opioids Misuse 
According to the 2017 National Survey on Drug Use and Health, the top reason for 
opioid misuse was to relieve physical pain (p. 21).6 This was followed by desires to experience 
a high or relax.  Only 2% of people reported misusing opioids because they were 
addicted.6 This may inform prevention efforts to increase public awareness of the highly 
addictive nature of opioids when misused.6
21
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Substance Use Initiation
Reasons for Opioids Misuse (continued)6
The following list provides the top reported reasons for opioid misuse in order of 
frequency.
1. Relieve physical pain (63%)
2. Feel good or get high (13%)
3. Relax or relieve tension (8%)
4. Help with sleep (5%)
5. Help with feelings or emotions (4%)
6. Experiment or see what drug was like (3%)
7. Because they were “hooked” or needed to have the drug (2%)
8. Increase or decrease the effects of other drugs (1%)
Source of Last Misused Pain Reliever (p. 21)6
In 2017, approximately half of misused pain relievers were obtained from friends or 
relatives, most of which were obtained for free (39%).6 Approximately one-third 
of misused pain relievers were obtained from a healthcare provider through either a 
prescription or stolen.6 According to the 2018 Midwest HIDTA report, the most 
often used methods of accessing CPDS include theft from family/friends, doctor shopping, and 
prescription fraud.3
Source Percentage
Received from friend/relative 53%
Healthcare provider (prescription or stolen) 37%
Bought from drug dealer or stranger 6%
Other source 5%
Table 3.3 Source of Prescription Pain Relievers
Regardless of the source, addiction to both medical and nonmedical opioids is the 
driving factor of the opioid crisis.  However, national data on opioid use disorders exclude 
those who are addicted to opioids that were prescribed to them.26
22
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Substance Use Initiation
Source of Last Misused Pain Reliever (p. 21)6
According to one study, four out of five heroin users began using opioids through 
prescription opioids (p. 560).26 Both heroin and prescription opioid initiation has 
been shown to lead to the misuse of other substances and more risky drug use behaviors, such 
as drug injection.  People perceive prescription pain relievers as less risky than heroin use or 
occasional marijuana use, but abuse liability is approximately the same.26 Furthermore, those 
who perceive low levels of opioid risk are nearly 10 times as likely to misuse opioids.
Polysubstance Use Preferences
Surveyed methamphetamine users identified they preferred using 
methamphetamine with alcohol and marijuana more than any other substance.6
Preferred Substances Used with Meth:
1. Alcohol (42%)
2. Cannabis (38%)
3. Powder cocaine (20%)
4. Crack Cocaine (19%)
5. Heroin (19%)
6. Alprazolam (18%)
Prescription Opioid Misuse to Heroin Initiation
Research has determined the initiation of non-medical prescription opioid use is a 
strong predictor of heroin initiation among U.S. veterans who reported no previous illicit drug 
use.36 The risk of heroin initiation was also higher for:
• Male individuals.
• Black and Hispanic individuals.
• Those with a history of mental illness.  
Screening veterans for prior or current prescription opioid misuse may play a 
significant role in the targeted prevention of heroin initiation.36 
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National Treatment Facilities
In 2017, approximately 1 in 13 Americans 
required substance use treatment.  For 
those ages 18-25 years old, however, this number 
was 1 in 7.8
SAMHSA identified three main types of 
substance abuse treatment in the 2017 National Survey
of Substance Abuse Treatment Services (N-SSATS):37
1. Outpatient.
• Regular
• Intensive
• Day treatment/partial hospitalization
• Detox
• Methadone maintenance
2. Residential or inpatient (approximately 2,752 facilities nationwide in 2017).
• Short-term (less than 30 days)
• Long-term (more than 30 days)
• Detox
3. Hospital inpatient (approximately 473 facilities nationwide in 2017).
• Treatment
• Detox
N-SSATS National data showed 13,585 substance abuse treatment facilities with 
approximately 1.3 million individuals receiving treatment on March 31, 2017.  Over half of these 
individuals were receiving treatment for drug abuse only.37
Nebraska Treatment Facilities
This report also includes data for Nebraska, using the same parameters for facilities 
and number of individuals receiving treatment.  Nebraska has 125 substance abuse 
treatment facilities which responded to the N-SSATS, with 6,461 clients reported in treatment 
on March 31, 2017, one-third of which were receiving treatment for drug abuse only.  The 
overwhelming majority of these clients (87%) were receiving outpatient treatment at that 
time.31
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Nebraska Treatment Facilities
• Outpatient: 5,604 (87%) clients
• Regular: 4385 (68%)
• Intensive: 606 (9%)
• Day treatment/partial 
hospitalization: 13 (0.2%)
• Detox: 65 (1%)
• Methadone maintenance: 535 (8%)
• Residential: 828 clients (13%)
• Short-term: 321 (5%)
• Long-term: 488 (8%)
• Detox: 19 (0.3%)
• Hospital inpatient: 29 (0.4%)
• Treatment: 12 (0.2%)
• Detox: 17 (0.3%)
• Opioid treatment programs (3 facilities, 0.2% of all OTP facilities in the U.S.)
• Any Medicated-Assisted Treatment: 560 (0.1%)
• Methadone: 427 (0.1%)
• Buprenorphine: 120 (0.4%)
• Naltrexone: 13 (0.4%)
(All OTP percentages are percentages of all clients in the U.S.)
Year Facilities Clients Clients/Facilities
2007 114 5,436 47.6
2009 114 4,864 42.6
2011 123 6,354 51.6
2013 114 6,374 55.9
2015 132 5,735 43.4
2017 125 6,461 51.6
Table 4.1 Nebraska Facilities and Clients in Treatment 2007-201737
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* “Completion of treatment” does not include transfers to another facility for further treatment, dismissals 
from treatment, dropouts from treatment, death of client, incarceration prior to treatment completion, or 
other termination of treatment prior to completion.4
Treatment Options
Facility Capacity and Utilization Rate
Residential Utilization Rate: 97%
• Residential Facilities: 33
• Residential Clients: 795
• Residential Beds: 816
Hospital Inpatient Utilization Rate: 7%
• HI Facilities: 1
• HI Clients: 2
• HI Beds: 29
Referrals to Treatment
Of those who completed treatment* in 2017, nearly half were self-referred to treatment 
(43%, n=688,306) and nearly one-third were referred by the criminal justice system (29%, 
n=463,595).8 The remaining 28% of discharges with admission data were referred by other 
community resources (10%, n=165,896), a substance use care provider (9%, n=147,669), 
school/education (7%, n=10,427), or an employer/EAP (<1%, n=5,852).8
Unmet Need for Treatment
Of the nearly 21 million people identified as needing substance use treatment in the 
2017 National Survey on Drug Use and Health, only 4 million people received treatment.6
While the treatment gap contains a greater number of people in the 26 and older age group, a 
larger percentage of the 18 to 25 age group lacked necessary substance use treatment.6
Age Group Need Received Treatment Treatment Gap
Age 12-17 1 million (4%) 184,000 (1%) 816,000
Age 18-25 5.2 million (15%) 641,000 (2%) 4,559,000
Age 26 or older 14.5 million (7%) 3.2 million (2%) 11,300,000
Total 20.7 million 4 million 15.3 million
Table 4.2 National Gap in Substance Use Treatment by Age6
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Barriers to Accessing Treatment
The list below displays the top reasons for people who feel they need treatment to not 
receive treatment.  The most frequently stated reason was not being ready to stop using.6
However, “not having health care coverage” and “concerns that it would have a negative effect on 
one’s job” closely followed.6
Reasons for not Receiving Treatment for Those Who Felt They Needed Treatment6
1. Not ready to stop using (40%)
2. No healthcare coverage (30%)
3. Might have negative effect on job (21%)
4. Might cause neighbors or community to have negative opinion (17%)
5. Did not know where to go for treatment (11%)
Another frequently reported reason for not receiving substance use treatment among 
those who felt they needed it involved concerns that it would negatively impact their 
job.6 However, buprenorphine is an effective opioid dependency treatment that allows 
people to continue working, regardless of profession.6
Methamphetamine Barriers to Accessing Treatment: 
The most common barrier to accessing methamphetamine treatment are psychosocial, 
such as embarrassment or stigma, preferring to go through withdrawal alone, or 
concerns regarding privacy.38 Practical barriers to methamphetamine treatment 
include lack of available services, waiting lists and waiting times, cost (for females in particular), 
and a lack of treatment services that accommodate women caring for dependent children.38
Methamphetamine Barriers Related to Service Providers: 
Among surveyed service providers, the behavior of patients was viewed a barrier to 
their treatment and resulted in some patients being asked to leave the facility until 
they are more stable.38 Service providers also noted a shortage of clinicians trained to 
treat methamphetamine dependency and a shortage of those trained to treat co-occurring 
polysubstance use and mental illness.38 Methamphetamine users also identified the negative 
perception of meth users from facility staff as a barrier to treatment.34
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Client Outreach
Just over 60% of treatment facilities nationwide provide outreach to those in the 
community who may need treatment.37 In Nebraska, approximately 50% of
treatment facilities provide outreach to community members.37
Evidence-Based Treatment Programs
Evidence-based treatment programs use models proven to be effective through high-
caliber research.  Overall, Nebraska utilized evidence-based treatment methods in 
conjunction with substance use treatment.  Table 4.3 shows national and Nebraska rates of 
treatment modality use.  Clinical therapeutic approaches “always or often” or “sometimes” 
used by treatment facility professional (p. 155):39
Treatments Used National Nebraska
Substance abuse counseling 99% 95%
Relapse prevention 96% 95%
Cognitive-behavioral therapy 94% 98%
Motivational Interviewing 93% 94%
Anger management 83% 84%
Brief intervention 82% 87%
12-step facilitation 73% 77%
Trauma-related counseling 79% 90%
Contingency management 56% 56%
Rational Emotive Behavioral therapy 46% 56%
Matrix Model 44% 42%
Computerized substance abuse treatment 15% 21%
Community reinforcement plus vouchers 12% 19%
Dialectical Behavior Therapy 55% 70%
Other treatment approaches 8% 6%
Table 4.3 Percent of Substance Use Treatment Facilities that use Evidence-Based 
Treatments for both Nebraska and Nationally
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Opioid Treatment Options
Methods of substance use treatment for opioid addiction and dependence (including 
prescription drugs, heroin, fentanyl) are:
1. Detox followed by abstinence.
2. Detox followed by monthly shots of naltrexone.
3. Medicated assisted treatment with buprenorphine.
4. Medicated assisted treatment with methadone.
Methamphetamine and Other Substance Treatment Options
Several treatment methods or models can be applied to the treatment of 
methamphetamine users.39 Examples of these methods are:
• The Matrix Model. 
This method of treatment is framed for users of methamphetamine and cocaine to aid 
in engaging users in treatment and helping achieve abstinence.  Several studies have 
shown a statistically significant reduction in drug use for individuals treated with this 
model.40
• Cognitive-Behavioral Therapy.
Originally developed to treat alcohol abuse, it has been adapted to address marijuana, 
cocaine, methamphetamine, and nicotine use.  This method focuses on teaching users 
to identify and correct problem behaviors by using skills to stop drug abuse and 
address problems that occur with drug abuse.40
• Contingency Management Interventions/Motivational Incentives.
Treatment methods that employ contingency management, which involves giving 
patients tangible rewards to reinforce positive behaviors like abstinence, have been 
shown to be highly efficient in-patient retention and abstinence.40
Opioids Alcohol Benzos Cocaine Meth Other 
Routine use of 
medications 
during detox
National 2,430 1,813 1,642 1,405 1,407 194 2,325
Nebraska 11 13 8 11 11 0 11
National 91% 68% 62% 53% 53% 7% 87%
Nebraska 79% 93% 57% 79% 79% 0% 79%
Table 4.4 Facilities Detoxifying Clients in 2017 by Substance (p. 165)39
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